To Launch Eribulin Mesylate Injection In Usa
02/09/2025 06:35
Sept 2 (Reuters) - Glenmark Pharmaceuticals GLEN.NS: TO LAUNCH ERIBULIN MESYLATE INJECTION IN USA TO BEGIN DISTRIBUTION IN SEPTEMBER 2025 Source text: ID:nBSE5B7S0j Further company coverage: GLEN.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Glenmark Pharmaceuticals
See all newsBrief: Glenmark Pharma Says Unit Launches Ryaltris Nasal Spray In Brazil For Allergic Rhinitis
Brief: Glenmark Pharma US Unit Launches Calcium Gluconate Injection USP In Multiple Vial Sizes
India's Glenmark Pharma gains most in three weeks on US approval for Flonase nasal spray
Brief: Glenmark Pharma Gets U.S. FDA Approval For Fluticasone Propionate Nasal Spray 0.05 Mg/Spray
India's Glenmark Pharmaceuticals falls as brokerage flags softer-than-expected quarter